New Ray Medicine International Holding Limited provided unaudited consolidated earnings guidance for the year ended 31 December 2019. Based on a preliminary review and analysis of the latest available unaudited consolidated financial information of the Company for the year ended 31 December 2019, it is expected that the Group will record a loss for fiscal 2019 as compared to a net profit attributable to owners of the Company of approximately HKD 33.2 million for the year ended 31 December 2018.